This week's roundup of Houston innovators includes Marc Nathan of Michael Best, Teresa Thomas of Deloitte, and Luis Arregoces of Blue People. Photos courtesy

Editor's note: Welcome to another Monday edition of Innovators to Know. Today I'm introducing you to three Houstonians to read up about — three individuals behind recent innovation and startup news stories in Houston as reported by InnovationMap. Learn more about them and their recent news below by clicking on each article.

Marc Nathan, senior director of market development at Michael Best

Headed to SXSW? Marc Nathan shares what you need to know. Photo via Michael Best

Tens of thousands of people are descending upon Austin for SXSW — many of whom are ambitious startup founders. For Houston entrepreneurs, there's a lot to consider before heading down the street to Austin, and Marc Nathan can help.

The native Houstonian, who works with startups as senior director of market development at Michael Best and is based in Austin, has attended the conference for over 20 years. Every year, he assembles a comprehensive SXSW guide including round up of must-attend events, tips, and more.

He joined the Houston Innovators Podcast this week to provide his thoughts on how Houston founders can make the most of the tech-focused Interactive track — or the unofficial experiences taking place around Austin.

"You do not need a badge to enjoy and get the most out of SXSW," Nathan says, explaining that having a badge is ideal for a first timer experience. "For struggling founders who are typically broke, if you can swing the travel to get to Austin — getting here, staying here, and eating here, which are all not very cheap to start with — if you can swing that, then a badge is not that critical." Read more.

Teresa Thomas, vice chair and national sector leader for energy and chemicals at Deloitte

Teresa Thomas, newly named vice chair and national sector leader for energy and chemicals at Deloitte, shares her vision in an interview. Photo via LinkedIn

Deloitte is undergoing a leadership shift — and this evolution for the nearly 200-year-old company directly affects its Houston office and the energy transition line of business.

Earlier this year, Teresa Thomas was named vice chair and national sector leader for energy and chemicals at Deloitte. Based in Houston, she will also serve as an advisory partner and leader in Deloitte & Touche LLP's Risk & Financial Advisory energy and chemicals practice. She succeeds Amy Chronis, partner at Deloitte LLP, who will continue to serve within the energy and chemicals practice until her retirement in June 2024. Read more.

Luis Arregoces, chief artificial intelligence officer at Blue People

Blue People has named Luis Arregoces as the company’s first chief artificial intelligence officer. Photo courtesy of Blue People

A Houston-based software company has named its first chief artificial intelligence officer.

Blue People has named Luis Arregoces as the company’s CAIO. With 20 years of experience, Arregoces has led AI projects for global Fortune 100 companies in various industries.

“I am honored to join Blue People and be a part of this historic moment,” Arregoces says in a news release. ”Together, we have the opportunity to shape the future of AI in Houston and beyond. AI’s versatility and transformative potential make it indispensable across all industries to drive innovations, efficiency, and competitiveness.” Read more.

Headed to SXSW? Here's what you need to know. Photo courtesy of SXSW

Podcast: The Houston founder's guide to navigating SXSW 2024

houston innovators podcast episode 227

Tens of thousands of people are descending upon Austin for SXSW — many of whom are ambitious startup founders. For Houston entrepreneurs, there's a lot to consider before heading down the street to Austin, and Marc Nathan can help.

The native Houstonian, who works with startups as senior director of market development at Michael Best and is based in Austin, has attended the conference for over 20 years. Every year, he assembles a comprehensive SXSW guide including round up of must-attend events, tips, and more.

He joined the Houston Innovators Podcast this week to provide his thoughts on how Houston founders can make the most of the tech-focused Interactive track — or the unofficial experiences taking place around Austin.

"You do not need a badge to enjoy and get the most out of SXSW," Nathan says, explaining that having a badge is ideal for a first timer experience. "For struggling founders who are typically broke, if you can swing the travel to get to Austin — getting here, staying here, and eating here, which are all not very cheap to start with — if you can swing that, then a badge is not that critical."

He also reminds founders that getting an invite to speak on a panel, pitch in the competition, or volunteering can score you a free or discounted badge.

On the show, Nathan shares more tips — from registering to everything you're even remotely interested in to making sure you have on your comfiest walking shoes and bring your external phone charger — on the podcast, but explains that there's really one big mistake new SXSW attendees should avoid.

"The biggest mistake I see year after year — and it's really an entrepreneur problem — but don't be too sales-y. Listen before you talk," Nathan says. "Everybody at SX is going to get it — they are going to understand the language you're speaking. It's not like explaining what your startup is to your 80-year-old grandmother. But you gotta give them a reason and a way to help you."

Headed out to SXSW? Here are a few Houston-focused events to attend.

March 9 - A $20 Trillion Challenge: Financing the Energy Transition (badge required)

A couple of Houstonians join the panel of a topic that is very prevalent in the energy capital of the world: funding of the energy transition. Juliana Garaizar joins the conversation on Saturday, March 9, at 4 pm.

March 10 - How NASA Supports Startups and Individuals to Collaborate on its Mission (badge required)

Last month, a Houston tech company launched a lunar lander in collaboration with NASA — and that's just one of countless examples of NASA's work with tech and startup companies. Join NASA for a panel discussing innovative partnerships on Sunday, March 10, at 4 pm.

March 11 - Houston House @ SXSW 2024 (badge required)

On Monday, March 11, at the LINE Hotel, the Greater Houston Partnership is hosting four panels and a happy hour. More info on the full-day event, which features over a dozen Houston-based experts, startup founders, and more, is available online.

March 12 - Women in VC Breakfast (registration required)

Houston Women in VC and Austin Women in VC are teaming up to host a breakfast with partners JP Morgan Chase and Born Global Ventures for all the female investors headed to SXSW on Tuesday, March 12, at 9 am. Request your registration online.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”